What's Your Legacy? How Clinical Trials Bridge Science to Medicine

In the past 20 years, many new medicines have become available for patients, providing new hope for managing or treating hundreds of diseases. Yet for so many people, treatment options remain limited or insufficient. For them, the search for other treatments — and hope — continues. To deliver for these patients, we need clinical research.

Clinical trials help researchers discover whether an investigational medicine is safe and effective for patients with a specific disease. Without clinical trials, there would be no new medicines.

For nearly four decades, Regeneron has harnessed the power of science to bring new treatments to patients — and clinical trials have helped us deliver our innovative discoveries to millions of people around the world.

Bringing science to patients

At Regeneron, we’ve always let science lead the way as we seek solutions for patients. That’s why, today, our scientific engine is more powerful than ever, and we have one of the industry’s most exciting and innovative pipelines. Today, that includes more than 40 molecules under investigation and almost 150 clinical trials in more than 50 countries.

Through clinical trials, we can investigate these molecules, answering more questions, developing more potentially life-changing medicines, and discovering more possibilities, all with the goal of improving human health.

Yet, despite this crucial research step, clinical trials often face recruiting challenges due to lack of awareness and misconceptions about participation. We’re working to help change that because through clinical trials, we can answer more questions, develop more potential treatments and discover more possibilities. So, memories can be made and moments shared, with the goal of offering more hope for patients and their loved ones.

Because we believe legacies aren't just meant to be left, they're meant to be lived.